PMDD Session Spotlight: Accelerate Proof Of Concept – Making the transition from project management to portfolio management

The 8th Annual Project and Portfolio Management for the Drug and Device Industry, September 20-21st in Boston, Massachusetts, is the only event designed by manufacturers for manufacturers to deliver advanced time saving and silo busting strategies proven to bring drugs and devices to market on time and on budget. Leading up to the event, the Future of Biopharma blog will be spotlighting some of the sessions you can look forward to at the the event.  For more information on the event, download the brochure here.

Session: Accelerate Proof Of Concept – Making the transition from project management to portfolio management

Featured Speaker: Dee Suberla, Sr. Consultant, Action for Results

About the session: Innovation to accelerate the drug development process is a hot topic in the life science industry.  Speeding up the seemingly standard development plan would mean hundreds of millions in cost savings. While there are ways to get a drug registered in the US and ex-US that don’t require that length of time, PMs aren’t currently taking advantage creative ways to accelerate programs.

In this session you will learn to:
• Design and implement an accelerated drug development strategy
• Conduct portfolio prioritization to enable early decision making
• Implement effective development and scenario planning
• Strategize for early decision making in pharma projects
• Establish interim assessment points and futility assessment points

Share this article with your social network, just click below to share now!

Share |

Top Reasons to Attend Project Management for the Drug & Device Industry

Have you considered joining us for the 7th Annual Project Management for the Drug & Device Industry event? It will be taking place Orlando, April 12-14, 2010 in Orlando.

Consider all you can gain from joining us in:
→ Understand and Apply Project Management Leadership Models in the Workplace
→ Master Lean Development and Management
→ Hear the Results of an Exclusive PM Benchmarking Survey
→ Boost Communication and Idea Exchange Using Social Media Tools
→ Succeed in Emerging Markets and with International Project Teams
→ Uncover New Opportunities for PM’s as Consultants or Contractors
→ Build a Successful PMO and Resource Management Function
→ Reduce Cycle Times in the Pharma R&D Process
→ Network and Collaborate With Hundreds of Your Industry Peers and access over 600 companies and nearly 2,000 clinical professionals
→ Understand the Impact of Healthcare Reform on the Industry with Insights from Senator Daschle
→ Earn up to 17.6 PDUs

Register before Friday, March 19 to save $200 and help lead your team confidently with clear strategies for achieving project, program and portfolio success in the evolving pharmaceutical and device industry.

Visit the webpage here.
Download the brochure here.

Share this article with your social network, just click below to share now!

Share |

The Meaningful Use Regulation of Healthcare Project Management

Recently, PM Boulevard looked at how American Recovery and Reinvestment Act (ARRA) is changing the way project management in healthcare organizations must change by 2015. In order to accomplish this, PMs must establish clear project management practices for their healthcare IT project managers.

The Meaningful Use regulations were defined, and we're currently in a 60 day comment period, as it was introduced on December 30, 2009, where:
It offers a 3 stage approach, offering incentive payments to eligible professionals and hospitals of up to $44,000. However, the real incentive is not to receive the reduction in Medicare/Medicaid payments beginning in 2016 that non-compliance will warrant.

Read the rest of the article here.

The 7th Annual Project Management for the Drug and Device Industry event has been designed to provide cutting-edge tools and techniques to help you lead your team confidently and walk away with clear strategies for achieving project, program and portfolio success.

Share this article with your social network, just click below to share now!

Share |

David Douglas of Pfizer joining us at Project Management for the Drug & Device Industry

On April 29th, David Douglas, Head of Project Management Center of Excellence at Pfizer will provide a critical assessment of the evolving drug development landscape and the impact on your day-to-day environment as a project manager. If you’re interested in understanding how to best position your PM strategy in light of recent M&A activity and the reduction in workforce, then you simply cannot miss this year’s Project Management for the Drug & Device Industry.

For more information on the Project Management for the Drug & Delivery Industry Conference, click here. If you'd like to network with other professionals in the field of project management in the drug industry, join our group of professionals at LinkedIn.

Share this article with your social network, just click below to share now!

Share |